How serious a cancer is MDS? What is the prognosis for MDS?
MDS expert, Dr Stephen Nimer, describes the prognosis of myelodysplastic syndromes (MDS). MDS is considered a type of cancer and prognosis varies dramatically depending on many factors, as described in the video in detail. Some patients may have less than 1 year to live from the time of their diagnosis, and others may live 10 or 15 years, or more. In some cases, MDS can progress to acute myeloid leukemia (AML) if it gets worse.
Share with family and friends:
Click here to take our Myelodysplastic Syndromes (MDS) SURVEY Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.
This educational activity has been developed by
the Myelodysplastic Syndromes Foundation, Inc and Mechanisms in Medicine Inc.
This activity is supported by an educational grant from Acceleron Pharma, Celgene Corporation, Jazz Pharmaceuticals, Novartis, and Takeda Oncology.
This website is part of the Animated Patient™ series developed by Mechanisms in Medicine Inc., to provide highly visual formats of learning for patients to improve their understanding, make informed decisions, and partner with their healthcare professionals for optimal outcomes.